Reducing the harmful effects of radiation on the gut.
Official title: Mitigation of Radiation Induced Gastrointestinal Syndrome.
Funded at Bcn Biosciences, LLC · NIH-10896967 · Data updated 2026-11-12
This study is looking at ways to help people who have had radiation therapy for cancer by finding treatments that can protect and heal their gut, making their recovery easier and improving their overall well-being.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bcn Biosciences, LLC NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,005,819 |
| NIH project number | 5R44AI177220-02 |
| Project ID | NIH-10896967 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients who have received radiation therapy and are experiencing gastrointestinal symptoms.
✕Less likely to help
Patients who have not undergone radiation therapy or do not exhibit gastrointestinal issues may not benefit from this research.
What this research studies
This research focuses on understanding and mitigating the gastrointestinal syndrome caused by radiation exposure. It aims to explore potential treatments that could protect or heal the gut lining after radiation therapy, which is often necessary for cancer treatment. The approach involves investigating biological mechanisms and testing various agents that may help reduce damage and promote recovery. Patients who have undergone radiation therapy may find this research particularly relevant as it seeks to improve their quality of life.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that alleviate gastrointestinal damage from radiation, improving recovery and overall health for patients.
How similar studies have gone: Previous research has shown promise in developing protective agents against radiation-induced damage, suggesting that this approach could yield beneficial results.
Where this research is happening
-
Bcn Biosciences, LLC
Pasadena, United States Active
Researchers
- Principal investigator: Norris, Andrew John — Bcn Biosciences, LLC
- Study coordinator: Norris, Andrew John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.